BPC-157, short for Body Protection Compound-157, is a synthetic peptide renowned for its potential anti-aging and regenerative effects
doi: 10.1007/s00706-005-0335-6
PlexusDx recommends ultrasound follow-up at 6 and 12 months for patients at moderate or high risk, and annually for lower-risk individuals
The safety profile of AOD-9604 is favorable compared to many metabolic interventions, with clinical trials involving approximately 900 participants demonstrating good tolerability and minimal side effects
The results of these experiments have been favorable, with benefits speculated to arise from metabolic modulation, cardiomyocyte apoptotic inhibition, reduced cardiac inflammation, and augmented endothelial function
Petersburg Institute of Bioregulation and Gerontology, it has since become one of the most referenced peptides in longevity-related science